haloperidol has been researched along with Frontotemporal Lobar Degeneration in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Frontotemporal Lobar Degeneration: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Frontotemporal lobar degeneration (FTLD) is the most common cause of early-onset dementia." | 1.36 | Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. ( Barcikowska, M; Blair, IP; Brooks, WS; Coupland, KG; Dobson-Stone, C; Halliday, GM; Karlström, H; Kwok, JB; Loy, CT; Luty, AA; Maruszak, A; Mather, KA; Panegyres, PK; Sachdev, PS; Schofield, PR; Sobow, T; Tchorzewska, J; Williams, KL; Zekanowski, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luty, AA | 1 |
| Kwok, JB | 1 |
| Dobson-Stone, C | 1 |
| Loy, CT | 1 |
| Coupland, KG | 1 |
| Karlström, H | 1 |
| Sobow, T | 1 |
| Tchorzewska, J | 1 |
| Maruszak, A | 1 |
| Barcikowska, M | 1 |
| Panegyres, PK | 1 |
| Zekanowski, C | 1 |
| Brooks, WS | 1 |
| Williams, KL | 1 |
| Blair, IP | 1 |
| Mather, KA | 1 |
| Sachdev, PS | 1 |
| Halliday, GM | 1 |
| Schofield, PR | 1 |
1 other study available for haloperidol and Frontotemporal Lobar Degeneration
| Article | Year |
|---|---|
Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.
Topics: Aged; Aged, 80 and over; Brain; Cell Line, Transformed; DNA-Binding Proteins; Female; Frontotemporal | 2010 |